Hyper-IgE in the allergy clinic--when is it primary immunodeficiency?
Jazyk angličtina Země Dánsko Médium print-electronic
Typ dokumentu časopisecké články, metaanalýza, práce podpořená grantem, přehledy
Grantová podpora
European Academy of Allergy and Clinical Immunology (EAACI) - International
PubMed
30043993
DOI
10.1111/all.13578
Knihovny.cz E-zdroje
- MeSH
- alergie krev diagnóza imunologie terapie MeSH
- diagnostické zobrazování MeSH
- diferenciální diagnóza MeSH
- fenotyp MeSH
- imunoglobulin E krev imunologie MeSH
- lidé MeSH
- management nemoci MeSH
- syndromy imunologické nedostatečnosti krev diagnóza etiologie terapie MeSH
- určení symptomu MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- metaanalýza MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Názvy látek
- imunoglobulin E MeSH
The 2017 International Union of Immunological Societies (IUIS) classification recognizes 3 hyper-IgE syndromes (HIES), including the prototypic Job's syndrome (autosomal dominant STAT3-loss of function) and autosomal recessive PGM3 and SPINK5 syndromes. Early diagnosis of PID can direct life-saving or transformational interventions; however, it remains challenging owing to the rarity of these conditions. This can result in diagnostic delay and worsen prognosis. Within increasing access to "clinical-exome" testing, clinicians need to be aware of the implication and rationale for genetic testing, including the benefits and limitations of current therapies. Extreme elevation of serum IgE has been associated with a growing number of PID syndromes including the novel CARD11 and ZNF341 deficiencies. Variable elevations in IgE are associated with defects in innate, humoral, cellular and combined immunodeficiency syndromes. Barrier compromise can closely phenocopy these conditions. The aim of this article was to update readers on recent developments at this important interface between allergy and immunodeficiency, highlighting key clinical scenarios which should draw attention to possible immunodeficiency associated with extreme elevation of IgE, and outline initial laboratory assessment and management.
Department of Allergy University Hospital Jiménez Díaz Foundation Madrid Spain
Department of Medicine Treviso Hospital University of Padova Padova Italy
Department of Molecular Medicine Sapienza University of Rome Rome Italy
Citace poskytuje Crossref.org